← Eichor
Condition: Ureter Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Ureter Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Uppe
Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT05775471Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Hist
Phase 2 · 4 location(s) · Emory University · NCT05756569Sacituzumab Govitecan Plus EV in Metastatic UC
Phase 1/Phase 2 · 1 location(s) · Dana-Farber Cancer Institute · NCT04724018A Novel Ureteric Stent in Kidney Stone Patients and Oncology Patients Compared to a Conventional JJ Stent
NA · 2 location(s) · University of Southampton · NCT06815120Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers
Phase 2 · 1 location(s) · Mayo Clinic · NCT07087860Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma
Phase 2/Phase 3 · 4 location(s) · University of British Columbia · NCT06124976Neoadjuvant Tislelizumab + Nab-Paclitaxel Followed by Distal Ureterectomy for Ureteral Cancer
Phase 2 · 1 location(s) · Tianjin Medical University Second Hospital · NCT07125547Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUC
Phase N/A · 2 location(s) · Peking University First Hospital · NCT06598761Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary
Phase 2/Phase 3 · 258 location(s) · National Cancer Institute (NCI) · NCT04628767Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Mic
Phase N/A · 1 location(s) · Yonsei University · NCT04625556uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Phase N/A · 22 location(s) · UroGen Pharma Ltd. · NCT05874921Spinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery
Phase 3 · 3 location(s) · Hans Bahlmann · NCT06349668Radiotherapy Combined with Systemic Therapy Versus Systemic Therapy for Oligometastatic UTUCs
NA · 2 location(s) · Peking University First Hospital · NCT06652022A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and U
NA · 1 location(s) · University of Washington · NCT06040762Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma
Phase 3 · 1 location(s) · University of Texas Southwestern Medical Center · NCT04865939Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma
NA · 4 location(s) · Case Comprehensive Cancer Center · NCT06262516Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · 499 location(s) · National Cancer Institute (NCI) · NCT05987241Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulati
Phase N/A · 1 location(s) · Yonsei University · NCT04197414Combined Postoperative Radiotherapy With Kidney Sparing Surgery for Locally Advanced High-risk Ureteral Cancer
Phase N/A · 2 location(s) · Xuesong Li · NCT06120387FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
Phase 1 · 82 location(s) · Eli Lilly and Company · NCT05614739Tandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral Obstruction
NA · 2 location(s) · Rabin Medical Center · NCT05992363Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma
Phase 2 · 1 location(s) · Nagoya University · NCT069832109MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma
Phase 2 · 2 location(s) · Mabwell (Shanghai) Bioscience Co., Ltd. · NCT06823427Integrated Cancer Repository for Cancer Research
Phase N/A · 42 location(s) · University of Nebraska · NCT02012699ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Phase N/A · 57 location(s) · Guardant Health, Inc. · NCT05059444Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and
Phase 4 · 1 location(s) · Mayo Clinic · NCT06764095Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/
Phase N/A · 1 location(s) · University of Washington · NCT01050504A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Phase 1 · 38 location(s) · Eli Lilly and Company · NCT06465069
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.